Fort Sheridan Advisors LLC Gilead Sciences, Inc. Transaction History

Fort Sheridan Advisors LLC

  • $526 Million
  • Q1 2024

A detailed history of Fort Sheridan Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 8,883 shares of GILD stock, worth $591,518. This represents 0.12% of its overall portfolio holdings.

Number of Shares
8,883
Previous 9,961 10.82%
Holding current value
$591,518
Previous $746,000 12.87%
% of portfolio
0.12%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $77,163 - $94,098
-1,078 Reduced 10.82%
8,883 $650,000
Q3 2023

Nov 08, 2023
BUY
$73.94 - $80.67 $73 - $80
1 Added 0.01%
9,961 $746,000
Q2 2023

Aug 01, 2023
BUY
$76.01 - $86.7 $18,850 - $21,501
248 Added 2.55%
9,960 $767,000
Q1 2023

May 12, 2023
BUY
$77.31 - $88.08 $203,943 - $232,355
2,638 Added 37.29%
9,712 $805,000
Q4 2022

Feb 15, 2023
SELL
$62.32 - $89.47 $18,820 - $27,019
-302 Reduced 4.09%
7,074 $607,000
Q3 2022

Nov 09, 2022
SELL
$59.54 - $68.01 $119 - $136
-2 Reduced 0.03%
7,376 $455,000
Q2 2022

Aug 08, 2022
BUY
$57.72 - $65.01 $3,463 - $3,900
60 Added 0.82%
7,378 $456,000
Q1 2022

May 09, 2022
BUY
$57.92 - $72.58 $10,888 - $13,645
188 Added 2.64%
7,318 $435,000
Q4 2021

Feb 10, 2022
SELL
$64.88 - $73.64 $107,376 - $121,874
-1,655 Reduced 18.84%
7,130 $518,000
Q3 2021

Nov 12, 2021
SELL
$67.69 - $73.03 $13,741 - $14,825
-203 Reduced 2.26%
8,785 $614,000
Q2 2021

Aug 17, 2021
BUY
$63.47 - $69.35 $158,357 - $173,028
2,495 Added 38.43%
8,988 $619,000
Q1 2021

May 17, 2021
BUY
$60.0 - $68.46 $1,980 - $2,259
33 Added 0.51%
6,493 $420,000
Q4 2020

Feb 16, 2021
BUY
$56.65 - $64.55 $11,330 - $12,910
200 Added 3.19%
6,460 $376,000
Q2 2020

Aug 14, 2020
SELL
$72.34 - $84.0 $65,901 - $76,524
-911 Reduced 12.7%
6,260 $482,000
Q1 2020

May 12, 2020
BUY
$62.63 - $80.22 $25,177 - $32,248
402 Added 5.94%
7,171 $536,000
Q4 2019

Feb 14, 2020
BUY
$61.62 - $67.78 $2,218 - $2,440
36 Added 0.53%
6,769 $440,000
Q3 2019

Nov 12, 2019
BUY
$62.51 - $69.0 $143,272 - $158,148
2,292 Added 51.61%
6,733 $427,000
Q2 2019

Aug 14, 2019
BUY
$61.87 - $69.38 $37,307 - $41,836
603 Added 15.71%
4,441 $300,000
Q1 2019

May 13, 2019
BUY
$62.53 - $70.05 $239,990 - $268,851
3,838 New
3,838 $250,000

Others Institutions Holding GILD

# of Institutions
1,885
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.5B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Fort Sheridan Advisors LLC Portfolio

Follow Fort Sheridan Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email